BiP immunohistochemical positivity is associated with HER2 expression and its nuclear expression was related to a higher tumor stage and poorer outcome, highlighting the potential of this protein as a prognostic indicator for breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.